EXACT SCIENCES CORPORATION

EXAS · NASDAQ

Diagnostic Imaging Centers · US

A leading provider of cancer screening and diagnostic tests, Exact Sciences relentlessly pursues smarter solutions providing the clarity to take life-changing action, earlier. Building on the success of Cologuard and Oncotype DX, Exact Sciences is investing in its product pipeline to take on some of the deadliest cancers and improve patient care. Exact Sciences unites visionary collaborators to help advance the fight against cancer.

Market Data

Price $103.37 -0.34 (-0.33%)

Market Cap$19.74B

P/E Ratio—

EPS$—

52W High$103.75

52W Low$38.81

Beta1.45

Data from Finnhub · Updated Mar 11, 2026